Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
Open Access
- 12 February 2007
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (33) , 4833-4841
- https://doi.org/10.1038/sj.onc.1210286
Abstract
Intestinal injury or chronic inflammation induce cytokines that promote crypt regeneration and mucosal repair. If excessive or prolonged, such mechanisms may increase colon cancer risk. Factors that terminate or limit cytokine action in intestinal epithelial cells (IEC) may protect against crypt hyperplasia and neoplasia. We hypothesized that suppressor of cytokine signaling-3 (SOCS3) is such a factor. Mice with Vilin-promoter/Cre-recombinase (VC)-mediated IEC-specific SOCS3 gene disruption (VC/HO), WT/HO littermates with floxed but intact SOCS3 genes and VC/WT mice were studied. Colon was examined after acute dextran sodium sulfate (DSS)-induced mucosal injury or after azoxymethane (AOM) and chronic DSS. Signaling pathways were examined in colon, cultured IEC or colon cancer cell lines. VC/HO mice showed no basal phenotype. After acute DSS, VC/HO exhibited enhanced crypt proliferation and crypt hyperplasia and reduced transforming growth factor (TGF) β expression in colon. Inflammation and mucosal damage were similar across genotypes. Following AOM/DSS, VC/HO mice had increased size, number and load of colonic tumors and increased STAT3 and nuclear factor-kappa B (NF-κB) activation in colon. In vitro, SOCS3 overexpression reduced proliferation, IL-6-mediated STAT3 activation and tumor necrosis factor (TNF) α-mediated NF-κB activation. We conclude that cytokine induction of SOCS3 normally provides an intrinsic mechanism to limit injury-induced crypt hyperproliferation and inflammation-associated colon cancer by regulating both STAT3 and NF-κB pathways.Keywords
This publication has 33 references indexed in Scilit:
- STAT3 Activation Regulates Growth, Inflammation, and Vascularization in a Mouse Model of Gastric TumorigenesisGastroenterology, 2006
- Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced HepatocarcinogenesisGastroenterology, 2006
- Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsProceedings of the National Academy of Sciences, 2006
- IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient miceThe Journal of Experimental Medicine, 2006
- Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 productionOncogene, 2006
- Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinomaOncogene, 2005
- Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cellsCarcinogenesis: Integrative Cancer Research, 2004
- Epigenetic inactivation of SOCS‐1 by CpG island hypermethylation in human gastric carcinomaInternational Journal of Cancer, 2004
- Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitisCytokine, 2004
- Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell–cell adhesion complexesOncogene, 2004